Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global Radioligand Therapy Market Research Report 2025

Global Radioligand Therapy Market Research Report 2025

Industry: Medical Devices & Consumables

Published Date: 2025-01-01

Pages: 79 Pages

Report ld: 3456468

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Radioligand Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Radioligand Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Radioligand Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Radioligand Therapy in Neuroendocrine Neoplasms is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Radioligand Therapy include Novartis, Advanced Accelerator Applications, Mercy Radiology, POINT Biopharma Global Inc, Fusion Pharma, Telix Pharmaceuticals Ltd, Lantheus Holdings, Inc, Bayer AG, Curium Pharma, Precirix, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Radioligand Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radioligand Therapy.

The Radioligand Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Radioligand Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Radioligand Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

MARKET SEGMENTATION

By Company

Novartis
Advanced Accelerator Applications
Mercy Radiology
POINT Biopharma Global Inc
Fusion Pharma
Telix Pharmaceuticals Ltd
Lantheus Holdings, Inc
Bayer AG
Curium Pharma
Precirix

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Actinium 225 (Ac-225)
Lutetium 177 (Lu-177)
Gallium 68 (Ga-68)
Fluorine 18 (F-18)
Other Radionuclides

Segment by Application

Neuroendocrine Neoplasms
Prostate Cancer

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Radioligand Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Radioligand Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Actinium 225 (Ac-225)

1.2.3 Lutetium 177 (Lu-177)

1.2.4 Gallium 68 (Ga-68)

1.2.5 Fluorine 18 (F-18)

1.2.6 Other Radionuclides

1.3 Market by Application

1.3.1 Global Radioligand Therapy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Neuroendocrine Neoplasms

1.3.3 Prostate Cancer

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Radioligand Therapy Market Perspective (2020-2031)

2.2 Global Radioligand Therapy Growth Trends by Region

2.2.1 Global Radioligand Therapy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Radioligand Therapy Historic Market Size by Region (2020-2025)

2.2.3 Radioligand Therapy Forecasted Market Size by Region (2026-2031)

2.3 Radioligand Therapy Market Dynamics

2.3.1 Radioligand Therapy Industry Trends

2.3.2 Radioligand Therapy Market Drivers

2.3.3 Radioligand Therapy Market Challenges

2.3.4 Radioligand Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Radioligand Therapy Players by Revenue

3.1.1 Global Top Radioligand Therapy Players by Revenue (2020-2025)

3.1.2 Global Radioligand Therapy Revenue Market Share by Players (2020-2025)

3.2 Global Radioligand Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Radioligand Therapy Revenue

3.4 Global Radioligand Therapy Market Concentration Ratio

3.4.1 Global Radioligand Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Radioligand Therapy Revenue in 2024

3.5 Global Key Players of Radioligand Therapy Head office and Area Served

3.6 Global Key Players of Radioligand Therapy, Product and Application

3.7 Global Key Players of Radioligand Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Radioligand Therapy Breakdown Data by Type

4.1 Global Radioligand Therapy Historic Market Size by Type (2020-2025)

4.2 Global Radioligand Therapy Forecasted Market Size by Type (2026-2031)

5 Radioligand Therapy Breakdown Data by Application

5.1 Global Radioligand Therapy Historic Market Size by Application (2020-2025)

5.2 Global Radioligand Therapy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Radioligand Therapy Market Size (2020-2031)

6.2 North America Radioligand Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Radioligand Therapy Market Size by Country (2020-2025)

6.4 North America Radioligand Therapy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Radioligand Therapy Market Size (2020-2031)

7.2 Europe Radioligand Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Radioligand Therapy Market Size by Country (2020-2025)

7.4 Europe Radioligand Therapy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Radioligand Therapy Market Size (2020-2031)

8.2 Asia-Pacific Radioligand Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Radioligand Therapy Market Size by Region (2020-2025)

8.4 Asia-Pacific Radioligand Therapy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Radioligand Therapy Market Size (2020-2031)

9.2 Latin America Radioligand Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Radioligand Therapy Market Size by Country (2020-2025)

9.4 Latin America Radioligand Therapy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Radioligand Therapy Market Size (2020-2031)

10.2 Middle East & Africa Radioligand Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Radioligand Therapy Market Size by Country (2020-2025)

10.4 Middle East & Africa Radioligand Therapy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Novartis

11.1.1 Novartis Company Details

11.1.2 Novartis Business Overview

11.1.3 Novartis Radioligand Therapy Introduction

11.1.4 Novartis Revenue in Radioligand Therapy Business (2020-2025)

11.1.5 Novartis Recent Development

11.2 Advanced Accelerator Applications

11.2.1 Advanced Accelerator Applications Company Details

11.2.2 Advanced Accelerator Applications Business Overview

11.2.3 Advanced Accelerator Applications Radioligand Therapy Introduction

11.2.4 Advanced Accelerator Applications Revenue in Radioligand Therapy Business (2020-2025)

11.2.5 Advanced Accelerator Applications Recent Development

11.3 Mercy Radiology

11.3.1 Mercy Radiology Company Details

11.3.2 Mercy Radiology Business Overview

11.3.3 Mercy Radiology Radioligand Therapy Introduction

11.3.4 Mercy Radiology Revenue in Radioligand Therapy Business (2020-2025)

11.3.5 Mercy Radiology Recent Development

11.4 POINT Biopharma Global Inc

11.4.1 POINT Biopharma Global Inc Company Details

11.4.2 POINT Biopharma Global Inc Business Overview

11.4.3 POINT Biopharma Global Inc Radioligand Therapy Introduction

11.4.4 POINT Biopharma Global Inc Revenue in Radioligand Therapy Business (2020-2025)

11.4.5 POINT Biopharma Global Inc Recent Development

11.5 Fusion Pharma

11.5.1 Fusion Pharma Company Details

11.5.2 Fusion Pharma Business Overview

11.5.3 Fusion Pharma Radioligand Therapy Introduction

11.5.4 Fusion Pharma Revenue in Radioligand Therapy Business (2020-2025)

11.5.5 Fusion Pharma Recent Development

11.6 Telix Pharmaceuticals Ltd

11.6.1 Telix Pharmaceuticals Ltd Company Details

11.6.2 Telix Pharmaceuticals Ltd Business Overview

11.6.3 Telix Pharmaceuticals Ltd Radioligand Therapy Introduction

11.6.4 Telix Pharmaceuticals Ltd Revenue in Radioligand Therapy Business (2020-2025)

11.6.5 Telix Pharmaceuticals Ltd Recent Development

11.7 Lantheus Holdings, Inc

11.7.1 Lantheus Holdings, Inc Company Details

11.7.2 Lantheus Holdings, Inc Business Overview

11.7.3 Lantheus Holdings, Inc Radioligand Therapy Introduction

11.7.4 Lantheus Holdings, Inc Revenue in Radioligand Therapy Business (2020-2025)

11.7.5 Lantheus Holdings, Inc Recent Development

11.8 Bayer AG

11.8.1 Bayer AG Company Details

11.8.2 Bayer AG Business Overview

11.8.3 Bayer AG Radioligand Therapy Introduction

11.8.4 Bayer AG Revenue in Radioligand Therapy Business (2020-2025)

11.8.5 Bayer AG Recent Development

11.9 Curium Pharma

11.9.1 Curium Pharma Company Details

11.9.2 Curium Pharma Business Overview

11.9.3 Curium Pharma Radioligand Therapy Introduction

11.9.4 Curium Pharma Revenue in Radioligand Therapy Business (2020-2025)

11.9.5 Curium Pharma Recent Development

11.10 Precirix

11.10.1 Precirix Company Details

11.10.2 Precirix Business Overview

11.10.3 Precirix Radioligand Therapy Introduction

11.10.4 Precirix Revenue in Radioligand Therapy Business (2020-2025)

11.10.5 Precirix Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Radioligand Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Actinium 225 (Ac-225)

Table 3. Key Players of Lutetium 177 (Lu-177)

Table 4. Key Players of Gallium 68 (Ga-68)

Table 5. Key Players of Fluorine 18 (F-18)

Table 6. Key Players of Other Radionuclides

Table 7. Global Radioligand Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Radioligand Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Radioligand Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Radioligand Therapy Market Share by Region (2020-2025)

Table 11. Global Radioligand Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Radioligand Therapy Market Share by Region (2026-2031)

Table 13. Radioligand Therapy Market Trends

Table 14. Radioligand Therapy Market Drivers

Table 15. Radioligand Therapy Market Challenges

Table 16. Radioligand Therapy Market Restraints

Table 17. Global Radioligand Therapy Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Radioligand Therapy Market Share by Players (2020-2025)

Table 19. Global Top Radioligand Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioligand Therapy as of 2024)

Table 20. Ranking of Global Top Radioligand Therapy Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Radioligand Therapy Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Radioligand Therapy, Headquarters and Area Served

Table 23. Global Key Players of Radioligand Therapy, Product and Application

Table 24. Global Key Players of Radioligand Therapy, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Radioligand Therapy Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Radioligand Therapy Revenue Market Share by Type (2020-2025)

Table 28. Global Radioligand Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Radioligand Therapy Revenue Market Share by Type (2026-2031)

Table 30. Global Radioligand Therapy Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Radioligand Therapy Revenue Market Share by Application (2020-2025)

Table 32. Global Radioligand Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Radioligand Therapy Revenue Market Share by Application (2026-2031)

Table 34. North America Radioligand Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Radioligand Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Radioligand Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Radioligand Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Radioligand Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Radioligand Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Radioligand Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Radioligand Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Radioligand Therapy Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Radioligand Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Radioligand Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Radioligand Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Radioligand Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Radioligand Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Radioligand Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 49. Novartis Company Details

Table 50. Novartis Business Overview

Table 51. Novartis Radioligand Therapy Product

Table 52. Novartis Revenue in Radioligand Therapy Business (2020-2025) & (US$ Million)

Table 53. Novartis Recent Development

Table 54. Advanced Accelerator Applications Company Details

Table 55. Advanced Accelerator Applications Business Overview

Table 56. Advanced Accelerator Applications Radioligand Therapy Product

Table 57. Advanced Accelerator Applications Revenue in Radioligand Therapy Business (2020-2025) & (US$ Million)

Table 58. Advanced Accelerator Applications Recent Development

Table 59. Mercy Radiology Company Details

Table 60. Mercy Radiology Business Overview

Table 61. Mercy Radiology Radioligand Therapy Product

Table 62. Mercy Radiology Revenue in Radioligand Therapy Business (2020-2025) & (US$ Million)

Table 63. Mercy Radiology Recent Development

Table 64. POINT Biopharma Global Inc Company Details

Table 65. POINT Biopharma Global Inc Business Overview

Table 66. POINT Biopharma Global Inc Radioligand Therapy Product

Table 67. POINT Biopharma Global Inc Revenue in Radioligand Therapy Business (2020-2025) & (US$ Million)

Table 68. POINT Biopharma Global Inc Recent Development

Table 69. Fusion Pharma Company Details

Table 70. Fusion Pharma Business Overview

Table 71. Fusion Pharma Radioligand Therapy Product

Table 72. Fusion Pharma Revenue in Radioligand Therapy Business (2020-2025) & (US$ Million)

Table 73. Fusion Pharma Recent Development

Table 74. Telix Pharmaceuticals Ltd Company Details

Table 75. Telix Pharmaceuticals Ltd Business Overview

Table 76. Telix Pharmaceuticals Ltd Radioligand Therapy Product

Table 77. Telix Pharmaceuticals Ltd Revenue in Radioligand Therapy Business (2020-2025) & (US$ Million)

Table 78. Telix Pharmaceuticals Ltd Recent Development

Table 79. Lantheus Holdings, Inc Company Details

Table 80. Lantheus Holdings, Inc Business Overview

Table 81. Lantheus Holdings, Inc Radioligand Therapy Product

Table 82. Lantheus Holdings, Inc Revenue in Radioligand Therapy Business (2020-2025) & (US$ Million)

Table 83. Lantheus Holdings, Inc Recent Development

Table 84. Bayer AG Company Details

Table 85. Bayer AG Business Overview

Table 86. Bayer AG Radioligand Therapy Product

Table 87. Bayer AG Revenue in Radioligand Therapy Business (2020-2025) & (US$ Million)

Table 88. Bayer AG Recent Development

Table 89. Curium Pharma Company Details

Table 90. Curium Pharma Business Overview

Table 91. Curium Pharma Radioligand Therapy Product

Table 92. Curium Pharma Revenue in Radioligand Therapy Business (2020-2025) & (US$ Million)

Table 93. Curium Pharma Recent Development

Table 94. Precirix Company Details

Table 95. Precirix Business Overview

Table 96. Precirix Radioligand Therapy Product

Table 97. Precirix Revenue in Radioligand Therapy Business (2020-2025) & (US$ Million)

Table 98. Precirix Recent Development

Table 99. Research Programs/Design for This Report

Table 100. Key Data Information from Secondary Sources

Table 101. Key Data Information from Primary Sources

Table 102. Authors List of This Report

List of Figures

Figure 1. Radioligand Therapy Picture

Figure 2. Global Radioligand Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Radioligand Therapy Market Share by Type: 2024 VS 2031

Figure 4. Actinium 225 (Ac-225) Features

Figure 5. Lutetium 177 (Lu-177) Features

Figure 6. Gallium 68 (Ga-68) Features

Figure 7. Fluorine 18 (F-18) Features

Figure 8. Other Radionuclides Features

Figure 9. Global Radioligand Therapy Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Radioligand Therapy Market Share by Application: 2024 VS 2031

Figure 11. Neuroendocrine Neoplasms Case Studies

Figure 12. Prostate Cancer Case Studies

Figure 13. Radioligand Therapy Report Years Considered

Figure 14. Global Radioligand Therapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Radioligand Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Radioligand Therapy Market Share by Region: 2024 VS 2031

Figure 17. Global Radioligand Therapy Market Share by Players in 2024

Figure 18. Global Top Radioligand Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioligand Therapy as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Radioligand Therapy Revenue in 2024

Figure 20. North America Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Radioligand Therapy Market Share by Country (2020-2031)

Figure 22. United States Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Radioligand Therapy Market Share by Country (2020-2031)

Figure 26. Germany Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Radioligand Therapy Market Share by Region (2020-2031)

Figure 34. China Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Radioligand Therapy Market Share by Country (2020-2031)

Figure 42. Mexico Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Radioligand Therapy Market Share by Country (2020-2031)

Figure 46. Turkey Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Novartis Revenue Growth Rate in Radioligand Therapy Business (2020-2025)

Figure 50. Advanced Accelerator Applications Revenue Growth Rate in Radioligand Therapy Business (2020-2025)

Figure 51. Mercy Radiology Revenue Growth Rate in Radioligand Therapy Business (2020-2025)

Figure 52. POINT Biopharma Global Inc Revenue Growth Rate in Radioligand Therapy Business (2020-2025)

Figure 53. Fusion Pharma Revenue Growth Rate in Radioligand Therapy Business (2020-2025)

Figure 54. Telix Pharmaceuticals Ltd Revenue Growth Rate in Radioligand Therapy Business (2020-2025)

Figure 55. Lantheus Holdings, Inc Revenue Growth Rate in Radioligand Therapy Business (2020-2025)

Figure 56. Bayer AG Revenue Growth Rate in Radioligand Therapy Business (2020-2025)

Figure 57. Curium Pharma Revenue Growth Rate in Radioligand Therapy Business (2020-2025)

Figure 58. Precirix Revenue Growth Rate in Radioligand Therapy Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Radioligand Therapy market? zhanKai

The top companies in the global Radioligand Therapy market are Novartis、Advanced Accelerator Applications、Mercy Radiology.

Related Reports

Radioligand Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Radioligand Therapy was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 110
USD 3950.00
(Single User License)
Global Radioligand Therapy Market Research Report 2026
The global Radioligand Therapy market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-17
Pages: 103
USD 2900.00
(Single User License)
Global Radioligand Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Radioligand Therapy market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 80
USD 4250.00
(Single User License)
Global Radioligand Therapy Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Radioligand Therapy market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-11-02
Pages: 128
USD 4900.00
(Single User License)
Radioligand Therapy- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Radioligand Therapy was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 91
USD 3950.00
(Single User License)
Global Radioligand Therapy Market Research Report 2024
The global Radioligand Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-06
Pages: 82
USD 2900.00
(Single User License)
Radioligand Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Radioligand Therapy was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-11
Pages: 109
USD 3950.00
(Single User License)

Radioligand Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Radioligand Therapy was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 110
USD 3950.00 (Single User License)
Global Radioligand Therapy Market Research Report 2026
The global Radioligand Therapy market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 103
USD 2900.00 (Single User License)
Global Radioligand Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Radioligand Therapy market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 80
USD 4250.00 (Single User License)
Global Radioligand Therapy Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Radioligand Therapy market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-02
Pages: 128
USD 4900.00 (Single User License)
Radioligand Therapy- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Radioligand Therapy was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 91
USD 3950.00 (Single User License)
Global Radioligand Therapy Market Research Report 2024
The global Radioligand Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-06
Pages: 82
USD 2900.00 (Single User License)
Radioligand Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Radioligand Therapy was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-11
Pages: 109
USD 3950.00 (Single User License)